In the present study, IL-6 was significantly shown to be modulated by TIMP-1 since genetically silencing TIMP-1 significantly decreased IL-6 mRNA and protein levels under normoxia, as well as hypoxia, the latter being a known critical player in tumor progression [35]. The gene discussed is TIMP1; the disease is neoplasm.